Nonseminomatous germ cell tumor
Nonseminomatous germ cell tumor
Explore linked clinical trials. Standard reference: MESH:M05323058 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, dysgerminoma, germinoma, germinomatous germ cell tumor, neoplasm, seminoma | Active, not recruiting | Phase 2 | 2026-09-18 | NCT03158064 | |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, choriocarcinoma, epithelial neoplasm, extragonadal seminoma, germinoma, malignant germ cell tumor, mesonephric neoplasm, mixed germ cell tumor, neoplasm, nongerminomatous germ cell tumor, pregnancy disorder, seminoma, teratoma, trophoblastic neoplasm, yolk sac tumor | Active, not recruiting | Phase 3 | 2026-06-16 | NCT02375204 | |
| Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Nonseminomatous germ cell tumor, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, benign urinary system neoplasm, carcinoma, cervical carcinoma, cervix disorder, cutaneous melanoma, endometrium adenocarcinoma, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, kidney cancer, kidney disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, prostate adenocarcinoma, sarcoma, skin disorder, skin neoplasm, transitional cell carcinoma, urinary system disorder, urothelial carcinoma, uterine disorder | Recruiting | Not applicable | 2026-06-15 | NCT06967961 | |
| Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, neoplasm, nongerminomatous germ cell tumor, ovarian germ cell tumor | Recruiting | Phase 2 | 2026-05-08 | NCT04804007 | |
| A Phase II Trial of Cabozantinib With Patients With Refractory GCTs | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, germinoma, neoplasm, nongerminomatous germ cell tumor, ovarian germ cell tumor, seminoma | Active, not recruiting | Phase 2 | 2026-01-15 | NCT04876456 | |
| Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, germinoma, neoplasm, seminoma | Recruiting | Not applicable | 2025-09-15 | NCT06133543 | |
| High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | Female Urogenital Diseases and Pregnancy Complications, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, Pregnancy Complications, Neoplastic, Urogenital Diseases, adenocarcinoma, carcinoma, choriocarcinoma, epithelial neoplasm, germinoma, mesonephric neoplasm, neoplasm, pregnancy disorder, seminoma, teratoma, trophoblastic neoplasm, yolk sac tumor | Recruiting | Phase 2 | 2025-08-03 | NCT06418789 | |
| Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors | Nonseminomatous germ cell tumor, nongerminomatous germ cell tumor | Recruiting | Not applicable | 2025-05-08 | NCT05705687 |